BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33606956)

  • 1. COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
    Segura de la Cal T; Nuche J; Jiménez López-Guarch C; Pérez-Olivares C; Cristo MJ; Oliver E; Escribano Subías P
    Ann Am Thorac Soc; 2021 Jun; 18(6):1080-1081. PubMed ID: 33606956
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: COVID-19 Experience and Pulmonary Arterial Hypertension: Do Earlier Theses and New Data Still Match?
    Lee JD; Burger CD; Rayner SG; Ryan JJ; Leary PJ
    Ann Am Thorac Soc; 2021 Jun; 18(6):1081-1082. PubMed ID: 33606954
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 and Pulmonary Arterial Hypertension: Early Data and Many Questions.
    Farha S; Heresi GA
    Ann Am Thorac Soc; 2020 Dec; 17(12):1528-1530. PubMed ID: 33258672
    [No Abstract]   [Full Text] [Related]  

  • 4. Case report of mild form of a new coronavirus infection in patient with idiopathic pulmonary hypertension.
    Gratsianskaya SE; Demchenkova AY; Martynyuk TV; Veselova TN; Ternovoy SK
    Kardiologiia; 2021 Oct; 61(10):108-112. PubMed ID: 34763646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical observations of COVID-19 infection in patients with chronic thromboembolic pulmonary hypertension.
    Kamenskaya OV; Loginova IY; Klinkova AS; Lomivorotov VV; Chernyavsky AM
    Kardiologiia; 2021 Jul; 61(6):28-34. PubMed ID: 34311685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin receptor antagonists for pulmonary arterial hypertension and COVID-19: Friend or foe?
    Badagliacca R; Sciomer S; Petrosillo N
    J Heart Lung Transplant; 2020 Jul; 39(7):729-730. PubMed ID: 32360293
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical course of COVID-19 in pulmonary arterial hypertension patients.
    Nuche J; Pérez-Olivares C; Segura de la Cal T; Jiménez López-Guarch C; Arribas Ynsaurriaga F; Escribano Subías P
    Rev Esp Cardiol (Engl Ed); 2020 Sep; 73(9):775-778. PubMed ID: 32540421
    [No Abstract]   [Full Text] [Related]  

  • 8. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
    Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S
    Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome.
    Lax SF; Skok K; Zechner PM; Trauner M
    Ann Intern Med; 2021 Jan; 174(1):139-140. PubMed ID: 33460547
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome.
    Nichols L
    Ann Intern Med; 2021 Jan; 174(1):139. PubMed ID: 33460548
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor.
    Lax SF; Skok K; Trauner M;
    Virchows Arch; 2020 Sep; 477(3):467-468. PubMed ID: 32772159
    [No Abstract]   [Full Text] [Related]  

  • 12. The pulmonary circuit dynamics in COVID-19!
    Magoon R
    J Anesth; 2021 Feb; 35(1):161. PubMed ID: 33128606
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced Rate of Hospital Admissions for heart failure and pulmonary hypertension during Covid-19 infection. Monocentric experience.
    Serra W
    Acta Biomed; 2021 May; 92(2):e2021184. PubMed ID: 33988140
    [No Abstract]   [Full Text] [Related]  

  • 14. PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic.
    Godinas L; Iyer K; Meszaros G; Quarck R; Escribano-Subias P; Vonk Noordegraaf A; Jansa P; D'Alto M; Luknar M; Milutinov Ilic S; Belge C; Sitbon O; Reis A; Rosenkranz S; Pepke-Zaba J; Humbert M; Delcroix M
    Orphanet J Rare Dis; 2021 May; 16(1):196. PubMed ID: 33933110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated clinical role of echocardiography in patients with COVID-19 disease.
    Lazzeri C; Bonizzoli M; Peris A
    Heart; 2020 Dec; 106(23):1864. PubMed ID: 33055152
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of the COVID-19 outbreak on an Italian cohort of systemic sclerosis patients.
    Bellan M; Parisi S; Stobbione P; Pedrinelli AR; Rizzi E; Casciaro GF; Vassia V; Landi R; Cittone MG; Rigamonti C; Patrucco F; Ditto MC; Finucci A; Realmuto C; Todoerti M; Parodi M; Rossi P; Pirisi M; Fusaro E; Sainaghi PP
    Scand J Rheumatol; 2020 Nov; 49(6):505-506. PubMed ID: 32856492
    [No Abstract]   [Full Text] [Related]  

  • 17. Coronavirus SARS-Cov-2 and arterial hypertension - facts and myths.
    Surma S; Romańczyk M; Łabuzek K
    Pol Merkur Lekarski; 2020 Jun; 48(285):195-198. PubMed ID: 32564046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired Right Ventricular Longitudinal Strain Without Pulmonary Hypertension in Patients Who Have Recovered From COVID-19.
    Nuzzi V; Castrichini M; Collini V; Roman-Pognuz E; Di Bella S; Luzzati R; Berlot G; Confalonieri M; Merlo M; Stolfo D; Sinagra G
    Circ Cardiovasc Imaging; 2021 Apr; 14(4):e012166. PubMed ID: 33827250
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhaled milrinone for sick COVID-19 cohort: A pathophysiology driven hypothesis!
    Magoon R; ItiShri ; Kohli JK; Kashav R
    Med Hypotheses; 2021 Jan; 146():110441. PubMed ID: 33308938
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk stratification of adults with congenital heart disease during the COVID-19 pandemic: insights from a multinational survey among European experts.
    Ruperti-Repilado FJ; Tobler D; Greutmann M; Bouchardy J; Ladouceur M; Dos-Subira L; Gallego P; Gabriel H; Bouma B; Schwerzmann M;
    Open Heart; 2021 Apr; 8(1):. PubMed ID: 33883228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.